MoscaLCollinsPHerringtonDMMendelsohnMEPasternakRCRobertsonRN. Hormone replacement therapy and cardiovascular disease: A statement for healthcare professionals from the American Heart Association. Circulation2001; 104: 499–503.
2.
AlexanderKPNewbyLKHellcampASHarringtonRAPetersonEDKopeckyS. Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up. J Am Coll Cardiol200138: 1–7.
3.
SchairerCLubinJTroisiRStugeonSBrintonLHooverR. Menopausal estrogen and estrogen—progestin replacement therapy and breast cancer risk. JAMA2000; 283: 485–91.
4.
RossRKPaganini-HillAWanPCPikeMC. Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin. J Natl Cancer Inst2000; 92: 328–32.
5.
RomieuIBerlinJColditzG. Oral contraceptives and breast cancer. Review and meta-analysis. Cancer1990; 66: 2253–63.
6.
MelbyeMWohlfahrtJOlsenJHFrischMWestergaardTHelwig-LarsenL. Induced abortion and the risk of breast cancer. N Engl J Med1997; 336: 81–5.
7.
BrindJChinchilliMSeversWBSummy-LongJ. Induced abortion as an independent risk factor for breast cancer: A comprehensive review and meta-analysis. J Epidemiol Community Health1996; 50: 481–96.
8.
KahlenbornC. Breast cancer: its link to abortion and the birth control pill. Dayton, OH: One More Soul, 2000: 92.
9.
McGregorDHLandCEChoiKTokuokaSLiuPIWakabayashiT. Breast cancer incidence among atomic bomb survivors, Hiroshima and Nagasaki, 1950–1969. J Natl Cancer Inst1977; 59: 799–811.
10.
ClarckRMChuaT. Breast cancer and pregnancy: The ultimate challenge. Clin Oncol1989; 1: 11–8.